Mereo BioPharma Group plc Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: Mereo BioPharma Group plc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2022 to Q3 2024.
Mereo BioPharma Group plc Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2024 was -$456M.

Retained Earnings (Accumulated Deficit), Quarterly (USD)

Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	-$456M			Sep 30, 2024	10-Q	2024-11-12
Q2 2024	-$441M			Jun 30, 2024	10-Q	2024-08-13
Q1 2024	-$429M			Mar 31, 2024	10-Q	2024-05-15
Q4 2023	-$420M	-$15.1M	-3.72%	Dec 31, 2023	10-Q	2024-11-12
Q4 2022	-$405M			Dec 31, 2022	10-K	2024-03-27

* An asterisk sign (*) next to the value indicates that the value is likely invalid.